Expertise in
28
conditions

Pascal P. Seve

103, Grande Rue De La Croix Rousse, 
Lyon, FR 
Expertise in
28
conditions
103, Grande Rue De La Croix Rousse, 
Lyon, FR 

Overview

Pascal Seve practices practicing medicine in Lyon, France.

Dr. Seve is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Sarcoidosis, Uveitis, Neurosarcoidosis, Vitrectomy, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 304 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

103, Grande Rue De La Croix Rousse, Lyon, 69004, France
Other Locations
Villeurbanne, 69100, France
Pierre-la-treiche, 69495, France
Bron, 69500, France
Saint-claude-de-diray, France
103 Grande Rue De La Croix Rousse 69317 Lyon, La Croix Rousse, 69317, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter Randomized Open-label Trial Comparing the Efficacy and Safety of Infliximab Versus Cyclophosphamide in Subjects With Idiopathic Refractory Scleritis
A Multicenter Randomized Open-label Trial Comparing the Efficacy and Safety of Infliximab Versus Cyclophosphamide in Subjects With Idiopathic Refractory Scleritis
Enrollment Status: Withdrawn
Publish Date: July 20, 2022
Intervention Type: Drug
Study Drugs: Infliximab, Cyclophosphamide
Study Phase: Phase 3
Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis : a Predictive Factor of Clinical Outcome? (MONITUX)
Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis : a Predictive Factor of Clinical Outcome? (MONITUX)
Enrollment Status: Terminated
Publish Date: November 16, 2020
Intervention Type: Other
View 1 Less Clinical Trial

304 Total Publications

Biophilic design: Could the healthcare environment become a therapeutic determinant?
Biophilic design: Could the healthcare environment become a therapeutic determinant?
Journal: La Revue de medecine interne
Published: June 23, 2026

Frequently Asked Questions about Pascal P. Seve

Is Pascal P. Seve a top-rated expert for Sarcoidosis?

MediFind is an objective health platform that identifies experts based on real-world data. Pascal P. Seve is classified as an Elite expert for Sarcoidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pascal P. Seve participate in research or clinical trials?

Yes. Pascal P. Seve has published 304 articles and abstracts on conditions like Sarcoidosis. You can view a list of Pascal P. Seve's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Seve's expertise for a condition
ConditionClose
View All 21 Advanced Conditions
View All 93 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile